[HTML][HTML] Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast …

HJ Burstein, G Curigliano, B Thürlimann, WP Weber… - Annals of oncology, 2021 - Elsevier
The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …

Breast cancer: an up‐to‐date review and future perspectives

R Hong, B Xu - Cancer communications, 2022 - Wiley Online Library
Breast cancer is the most common cancer worldwide. The occurrence of breast cancer is
associated with many risk factors, including genetic and hereditary predisposition. Breast …

Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology

WJ Gradishar, MS Moran, J Abraham, R Aft… - Journal of the National …, 2022 - jnccn.org
The therapeutic options for patients with noninvasive or invasive breast cancer are complex
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

F Cardoso, S Kyriakides, S Ohno… - Annals of …, 2019 - annalsofoncology.org
In 2018, the predicted number of new breast cancers in 28 European Union (EU) countries
was 404 920, with estimated age-adjusted annual incidence of breast cancer of 144.9/100 …

[HTML][HTML] Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast …

HJ Burstein, G Curigliano, S Loibl, P Dubsky, M Gnant… - Annals of …, 2019 - Elsevier
Abstract Background The 16th St. Gallen International Breast Cancer Conference 2019 in
Vienna, Austria reviewed substantial new evidence on loco-regional and systemic therapies …

Management of the axilla in early-stage breast cancer: Ontario Health (Cancer Care Ontario) and ASCO guideline

M Brackstone, FG Baldassarre, FE Perera… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To provide recommendations on the best strategies for the management and on
the best timing and treatment (surgical and radiotherapeutic) of the axilla for patients with …

[HTML][HTML] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of …

G Curigliano, HJ Burstein, EP Winer, M Gnant… - Annals of …, 2017 - Elsevier
ABSTRACT The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna,
Austria reviewed substantial new evidence on loco-regional and systemic therapies for early …

Fluorescence image-guided tumour surgery

K Wang, Y Du, Z Zhang, K He, Z Cheng, L Yin… - Nature Reviews …, 2023 - nature.com
Intraoperative fluorescent imaging can provide real-time identification of tumours, lymph
nodes, nerves and other healthy and malignant tissues during oncological surgery …

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

E Senkus, S Kyriakides, S Ohno… - Annals of …, 2015 - annalsofoncology.org
In 2012, the estimated age-adjusted annual incidence of breast cancer in 40 European
countries was 94.2/100 000 and the mortality 23.1/100 000 [1]. The incidence increased …

Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype

WF Symmans, C Wei, R Gould, X Yu… - Journal of Clinical …, 2017 - ascopubs.org
Purpose To determine the long-term prognosis in each phenotypic subset of breast cancer
related to residual cancer burden (RCB) after neoadjuvant chemotherapy alone, or with …